NCT03616158View on ClinicalTrials.gov

Investigate the Development and Progression of Lung Disease in Rheumatoid Arthritis Over Time

UnknownOBSERVATIONAL
Enrollment

340

Participants

Timeline

Start Date

May 10, 2018

Primary Completion Date

May 10, 2023

Study Completion Date

December 1, 2024

Conditions
Rheumatoid ArthritisLung Diseases
Trial Locations (1)

80206

RECRUITING

National Jewish Health, Denver

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

National Jewish Health

OTHER

NCT03616158 - Investigate the Development and Progression of Lung Disease in Rheumatoid Arthritis Over Time | Biotech Hunter | Biotech Hunter